James Essell

Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study

Alison R. Sehgal, Daanish Hoda, Peter A. Riedell et al. · The Lancet Oncology · 2022 · 217 citations

Hematological Malignancy, Lymphoid Neoplasia, Transplantation +10

Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study

Howard A. Burris, Ian W. Flinn, Manish R. Patel et al. · The Lancet Oncology · 2018 · 202 citations

Hematological Malignancy, Tumor Biology, Lymphoid Neoplasia +10

Ursodiol Prophylaxis against Hepatic Complications of Allogeneic Bone Marrow Transplantation

James Essell · Annals of Internal Medicine · 1998 · 190 citations

ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease

Madan Jagasia, Aleksandr Lazaryan, Carlos Bachier et al. · Journal of Clinical Oncology · 2021 · 174 citations · Full text

Comparison of thromboelastography to bleeding time and standard coagulation tests in patients after cardiopulmonary bypass

James Essell, Thomas J. Martin, John T. Salinas et al. · Journal of Cardiothoracic and Vascular Anesthesia · 1993 · 168 citations

Pulmonary Embolism, Thrombosis, Venous Thrombosis +13